Cargando…

Depressive symptoms in Parkinson’s disease and in non-neurological medical illnesses

BACKGROUND: Patients with neurological and non-neurological medical illnesses very often complain of depressive symptoms that are associated with cognitive and functional impairments. We compared the profile of depressive symptoms in Parkinson’s disease (PD) patients with that of control subjects (C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assogna, Francesca, Fagioli, Sabrina, Cravello, Luca, Meco, Giuseppe, Pierantozzi, Mariangela, Stefani, Alessandro, Imperiale, Francesca, Caltagirone, Carlo, Pontieri, Francesco E, Spalletta, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615851/ https://www.ncbi.nlm.nih.gov/pubmed/23569379 http://dx.doi.org/10.2147/NDT.S40013

Ejemplares similares

Psychiatric profile of motor subtypes of de novo drug‐naïve Parkinson's disease patients
por: Assogna, Francesca, et al.
Publicado: (2018)

Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism
por: Assogna, Francesca, et al.
Publicado: (2019)

Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson’s Disease and Is Associated with Motor Symptom Severity
por: Ciaramella, Antonio, et al.
Publicado: (2013)

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Assogna, Francesca, et al.
Publicado: (2021)

Drug Choices and Advancements for Managing Depression in Parkinson's Disease
por: Assogna, Francesca, et al.
Publicado: (2020)

Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study
por: Spalletta, Gianfranco, et al.
Publicado: (2014)

Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson’s disease patients
por: Hamid, Zeeshan, et al.
Publicado: (2019)

Brain microstructural changes and cognitive correlates in patients with pure obsessive compulsive disorder
por: Spalletta, Gianfranco, et al.
Publicado: (2014)

Immune System and Neuroinflammation in Idiopathic Parkinson’s Disease: Association Analysis of Genetic Variants and miRNAs Interactions
por: Strafella, Claudia, et al.
Publicado: (2021)

Action Observation With Dual Task for Improving Cognitive Abilities in Parkinson’s Disease: A Pilot Study
por: Caligiore, Daniele, et al.
Publicado: (2019)

Cortical Grey Matter and Subcortical White Matter Brain Microstructural Changes in Schizophrenia Are Localised and Age Independent: A Case-Control Diffusion Tensor Imaging Study
por: Chiapponi, Chiara, et al.
Publicado: (2013)

Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia
por: Palladino, Ilaria, et al.
Publicado: (2012)

Cerebellar GABA Levels and Cognitive Interference in Parkinson’s disease and Healthy Comparators
por: Piras, Federica, et al.
Publicado: (2020)

Subclinical Cognitive and Neuropsychiatric Correlates and Hippocampal Volume Features of Brain White Matter Hyperintensity in Healthy People
por: Spalletta, Gianfranco, et al.
Publicado: (2020)

Hippocampal volume and depressive symptoms are linked to serum IL-18 in schizophrenia
por: Bossù, Paola, et al.
Publicado: (2015)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
por: Bossù, Paola, et al.
Publicado: (2018)

Foot Pressure Wearable Sensors for Freezing of Gait Detection in Parkinson’s Disease
por: Marcante, Andrea, et al.
Publicado: (2020)

Narrative discourse production in Parkinson’s disease: Decoupling the role of cognitive-linguistic and motor speech changes
por: D’Ascanio, Sara, et al.
Publicado: (2023)

Myeloid dendritic cells are decreased in peripheral blood of Alzheimer’s disease patients in association with disease progression and severity of depressive symptoms
por: Ciaramella, Antonio, et al.
Publicado: (2016)

Effectiveness of a Family Support Intervention on Caregiving Burden in Family of Elderly Patients With Cognitive Decline After the COVID-19 Lockdown
por: Cravello, Luca, et al.
Publicado: (2021)

Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors
por: Musicco, Massimo, et al.
Publicado: (2009)

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
por: Liguori, Claudio, et al.
Publicado: (2022)

High serum levels of transforming growth factor β1 are associated with increased cortical thickness in cingulate and right frontal areas in healthy subjects
por: Piras, Fabrizio, et al.
Publicado: (2012)

New evidence for the cerebellar involvement in personality traits
por: Picerni, Eleonora, et al.
Publicado: (2013)

Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease
por: Liguori, Claudio, et al.
Publicado: (2015)

Chronic Pain in the Elderly with Cognitive Decline: A Narrative Review
por: Cravello, Luca, et al.
Publicado: (2019)

Cognitive Performance following Carotid Endarterectomy or Stenting in Asymptomatic Patients with Severe ICA Stenosis
por: Picchetto, Livio, et al.
Publicado: (2013)

Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease
por: Carlesimo, Giovanni A., et al.
Publicado: (2015)

Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study
por: Colombo, Delia, et al.
Publicado: (2018)

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
por: De Masi, Claudia, et al.
Publicado: (2022)

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
por: Pisani, Valerio, et al.
Publicado: (2012)

Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study
por: Carpi, Matteo, et al.
Publicado: (2023)

Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases
por: Bossù, Paola, et al.
Publicado: (2015)

Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease
por: Sisto, Renata, et al.
Publicado: (2020)

Prodromal non-motor symptoms of Parkinson’s disease
por: Pellicano, Clelia, et al.
Publicado: (2007)

Influence of APOE and RNF219 on Behavioral and Cognitive Features of Female Patients Affected by Mild Cognitive Impairment or Alzheimer’s Disease
por: Mosca, Alessandra, et al.
Publicado: (2018)

Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?
por: Stefani, Alessandro, et al.
Publicado: (2022)

White matter hyperintensities segmentation: a new semi-automated method
por: Iorio, Mariangela, et al.
Publicado: (2013)

The Italian Validation of the Beck Cognitive Insight Scale: Underlying Factor Structure in Psychotic Patients and the General Population
por: Orfei, Maria Donata, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mlv3qcif1acohc2g6l0ib6uvkd